Neumora is at the forefront of developing precision medicines aimed at enhancing brain health and well-being. Leveraging advanced biotechnology, the company focuses on innovative therapeutic solutions to address neurological disorders, contributing to a transformative era in the Pharmaceuticals and Biotechnology industries.
Specialties
Precision medicines for brain health
Innovative therapies for neurological disorders
Advanced biotechnology applications
Transformative pharmaceutical solutions
Focus on patient-centric outcomes
Products & Services
Precision Medicines
Neurological Disorder Therapies
Biotechnology Solutions
Brain Health Enhancers
Innovative Therapeutic Approaches
Contact Information
No contact information available
Competitors & Similar Companies(9)
Biogen
Massachusetts, • United States
Amgen
California, • United States
Novo Nordisk
New Jersey, • United States
Sage Therapeutics
Massachusetts, • United States
Axovant Gene Therapies
Basel-City, • Switzerland
Acadia Pharmaceuticals
California, • United States
Alnylam Pharmaceuticals
Massachusetts, • United States
Neurocrine Biosciences
California, • United States
Evoke Pharma
News & Media
Search Terms:
neumora
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Competitors of Neumora are Biogen, Amgen, Novo Nordisk, Sage Therapeutics, Axovant Gene Therapies, Acadia Pharmaceuticals, Alnylam Pharmaceuticals, Neurocrine Biosciences, Evoke Pharma.
What does Neumora do?
Neumora is at the forefront of developing precision medicines aimed at enhancing brain health and well-being. Leveraging advanced biotechnology, the company focuses on innovative therapeutic solutions to address neurological disorders, contributing to a transformative era in the Pharmaceuticals and Biotechnology industries.